Edwards Lifesciences Corp (NYSE:EW)
$ 89.78 0.64 (0.72%) Market Cap: 54.10 Bil Enterprise Value: 52.72 Bil PE Ratio: 38.70 PB Ratio: 7.60 GF Score: 98/100

Q1 2019 Edwards Lifesciences Corp Earnings Call Transcript

Apr 23, 2019 / 09:00PM GMT
Release Date Price: $60.33 (+1.53%)
Operator

Welcome, and thank you for joining us today. Just after the close of regular trading, Edwards Lifesciences released its first quarter 2019 financial results. During today's call, management will discuss the results included in the press release and accompanying financial schedules and then use the remaining time for Q&A. Our presenters on today's call are Mike Mussallem, Chairman and CEO; and Scott Ullem, CFO.

Before we begin, I'd like to remind you that during today's call, management will be making forward-looking statements that are based on estimates, assumptions and projections. These statements include, but aren't limited to, financial guidance and expectations for longer-term growth opportunities, regulatory approvals, clinical trials, litigation, reimbursement, competitive matters and foreign currency fluctuations. These statements speak only as of the date on which they are made, and Edwards does not undertake any obligation to update them after today.

Additionally, the statements involve risks and uncertainties that could cause actual results to differ materially.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot